PIM Brands names Tom Gargiulo as chief revenue officer
The move reflects PIM Brands' commitment to integrated commercial leadership bridging marketing and sales to continue driving year-over-year double digit expansion.
The move reflects PIM Brands' commitment to integrated commercial leadership bridging marketing and sales to continue driving year-over-year double digit expansion.
Through a comic-style social media campaign, CRN is advocating for supplement transparency legislation designed to improve FDA visibility into products on the market.
In honor of Mental Health Awareness Month, the collaboration builds on the joy of ice cream by encouraging deeper self-care through 'Therapy in a Pint.'
The innovative solutions are designed to support everyday eye comfort with gentle cleansing and dry eye relief for consumers experiencing screen-related eye fatigue.
HI-CHEW unveils Lychee & Raspberry stick at Walgreens, combining tart raspberry with sweet lychee and refreshed packaging for the 2026 Sweets & Snacks Expo.
Featuring new SKITTLES POP’d Creepy Crunch and TWIX Skulls, the Mars lineup taps into consumer demand for innovative textures and festive shapes.
The reformulated Chips & Chunks features 33% more total chocolate vs. the original recipe; the kind of upgrade only the Keebler Elves could deliver.
Molson Canadian brings “Cheer Canadian” to Buffalo, celebrating fans who united for the Canadian anthem.
Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL, is bioequivalent to the reference listed drug (RLD), Ravicti® Oral Liquid, 1.1 grams per mL, of Horizon Therapeutics U.S. Holding LLC.
The falsies created a look that felt both soft and dramatically refined.
America's No. 1 cat food brand puts a stamp of approval on bold behavior, playful chaos and the people who embrace it.
New Chapter brings three targeted formulas for joint comfort, skin health and beauty nourishment to Erewhon.
Science-backed microbiome supplements resM™ and resG prebeet debut on shelves nationwide, bringing Gut-X Axis innovation to millions of consumers.
These results reinforce the roles of IL-4 and IL-13, two of the key and central drivers of type 2 inflammation, in EoE.
“In line with the 2026 theme, 'Costume Art,' the nails were created as an extension of Venus Williams’ dress."
Announcements from both are in line with a federal push for US-produced drugs.